Literature DB >> 24097324

[Bilateral sensorineural hearing impairment due to Streptococcus suis meningitis 20 days after swine bite].

Kousuke Mori1, Nobuyuki Ishii, Hitoshi Mochizuki, Akitoshi Taniguchi, Kazutaka Shiomi, Masamitsu Nakazato.   

Abstract

Streptococcus suis (S. suis) is a zoonotic pathogen in pigs, which can be transmitted to humans by close contact. Meningitis is the most common clinical manifestations of S. suis infection and hearing impairment is a frequent complication. The risk of S. suis meningitis is higher in people who work in the swine industry. The patient was a 53-year-old woman working in the swine industry, who developed headache and fever 20 days after a swine bite. She was diagnosed as meningitis and S. suis was detected in the cerebrospinal fluid. We treated her with ceftriaxone, vancomycin, and dexamethasone, and signs of meningeal irritation diminished three days after admission. However, bilateral sensorineural hearing impairment occurred on the ninth day after admission. We added methylprednisolone (500 mg, 2 days) but moderate hearing impairment remained on the left. Antibiotic therapy should be considered for wounds of people involved in the swine industry for preventing S. suis infection.When S. suis meningitis occurs, symptoms of hearing impairment must be monitored carefully.

Entities:  

Mesh:

Year:  2013        PMID: 24097324     DOI: 10.5692/clinicalneurol.53.732

Source DB:  PubMed          Journal:  Rinsho Shinkeigaku        ISSN: 0009-918X


  2 in total

1.  A fishy tale: a man with empyema caused by Streptococcus halichoeri.

Authors:  Rui Min Foo; Douglas Chan
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

Review 2.  Streptococcus suis, an important pig pathogen and emerging zoonotic agent-an update on the worldwide distribution based on serotyping and sequence typing.

Authors:  Guillaume Goyette-Desjardins; Jean-Philippe Auger; Jianguo Xu; Mariela Segura; Marcelo Gottschalk
Journal:  Emerg Microbes Infect       Date:  2014-06-18       Impact factor: 7.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.